Improved homogeneous proximity-based screening assay of potential inhibitors of 17β-hydroxysteroid dehydrogenases

Assay and Drug Development Technologies

Volumn 4, Issue 6, 2006, Pages 671-678

  Kokko, Leena ^a   Jaakohuhta, Sinikka ^a,c   Lindroos, Pia ^b   Soukka, Tero ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b Hormos Medical Ltd   (Finland)

^c Raisio Oyj   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; RECOMBINANT ENZYME; TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; CATALYSIS; CELL ASSAY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; ENZYME MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; IMMUNOASSAY; INTERMETHOD COMPARISON; PROCESS OPTIMIZATION; PROXIMITY BASED SCREENING ASSAY; SENSITIVITY ANALYSIS;

17-HYDROXYSTEROID DEHYDROGENASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; IMMUNOASSAY; RECOMBINANT PROTEINS;

EID: 33846624232     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2006.4.671     Document Type: Article

References (26)

1. Mindnich R, Möller G, Adamski J: The role of 17 beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2004; 218:7-20.
2. Adamski J, Jakob FJ: A guide to 17β-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2001;171:1-4.
3. Baker ME: Evolution of 17β-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action. Mol Cell Endocrinol 2001;171:211-215.
4. Vihko P, Härkönen P, Oduwole O, Törn S, Kurkela R, Porvari K, et al.: 17β-Hydroxysteroid dehydrogenases and cancers. J Steroid Biochem Mol Biol 2003;83:119-122.
5. Vihko P, Härkönen P, Soronen P, Törn S, Herrala A, Kurkela R, et al.: 17β-Hydroxysteroid dehydrogenases - their role in pathophysiology. Mol Cell Endocrinol 2004;215:83-88.
6. Poutanen M, Isomaa V, Peltoketo H, Vihko R: Role of 17 beta-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesis. J Steroid Biochem Mol Biol 1995;55:525-532.
7. Puranen T, Poutanen M, Ghosh D, Vihko R, Vihko P: Origin of substrate specificity of human and rat 17beta-hydroxysteroid dehydrogenase type 1, using chimeric enzymes and site-directed substitutions. Endocrinology 1997;138:3532-3539.
8. Miettinen M, Isomaa V, Peltoketo H, Ghosh D, Vihko P: Estrogen metabolism as a regulator of estrogen action in the mammary gland. J Mammary Gland Biol Neoplasia 2000;5:259-270.
9. Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, et al.: Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab 1996;81:4042-4046.
10. Miyoshi Y, Ando A, Shiba E, Taguchi T, Tamaki Y, Noguchi S: Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers. Int J Cancer 2001;94:685-689.
11. Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S: Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J Biol Chem 1993; 268:12964-12969.
12. Casey ML, MacDonald PC, Andersson S: 17 Beta-hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest 1994;94:2135-2141.
13. Mustonen MV, Poutanen MH, Kellokumpu S, de Launoit Y, Isomaa VV, Vihko RT, et al.: Mouse 17β-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts. J Mol Endocrinol 1998;20:67-74.
14. Speirs V, Green AR, Atkin SL: Activity and gene espression of 17β-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissues: the role of IL-8. J Steroid Biochem Mol Biol 1998;67:267-274.
15. Luu-The V, Zhang Y, Poirier D, Labrie F: Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: oxidation/ reduction and inhibition. J Steroid Biochem Mol Biol 1995;55:581-587.
16. Pácha J, Miksik I, Lisá V, Pohlová I: Hormonal regulation of intestinal 11 beta-hydroxysteroid dehydrogenase. Life Sci 1997;61:2391-2396.
17. Mundt S, Solly K, Thieringer R, Hermanowski-Vosatka A: Development and application of a scintillation proximity assay (SPA) for identification of selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1. Assay Drug Dev Technol 2005;3:367-375.
18. Solly K, Mundt S, Zokian H, Juy-Fang Ding G, Hermanowski-Vosatka A, Strulovici B, et al.: High-throughput screening of 11β-hydroxysteroid dehydrogenase type 1 in scintillation proximity assay format. Assay Drug Dev Technol 2005;3:377-384.
19. Kokko L, Sandberg K, Lövgren T, Soukka T: Europium(III) chelate-dyed nanoparticles as donors in a homogeneous proximity-based immunoassay for estradiol. Anal Chim Acta 2004;503:155-162,
20. Kokko L, Johansson N, Soukka T, Lövgren T: Enzyme inhibitor screening using proximity based homogeneous immunoassay. J Biomol Screen 2005;10:348-354.
21. Lamminmäki U, Paupério S, Westerlund-Karlsson A, Karvinen J, Virtanen PL, Lövgren T, et al.: Expanding the conformational diversity by random insertions to CDRH2 results in improved anti-estradiol antibodies. J Mol Biol 1999;291:589-602.
22. Mikola H, Hänninen E: Introduction of aliphatic amino and hydroxy groups to keto steroids using O-substituted hydroxylamines. Bioconj Chem 1992;3:182-186.
23. Miettinen MM, Poutanen MH, Vihko RK: Characterization of estrogen-dependent growth of cultured MCF-7 human breast-cancer cells expressing 17β-hydroxysteroid dehydrogenase type 1. Int J Cancer 1996;68:600-604.
24. Zhang JH, Chung TDY, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4: 67-73.
25. Spires TE, Fink BE, Kick EK, You D, Rizzo CA, Takenaka I, et al.: Identification of novel functional inhibitors of 17beta-hydroxysteroid dehydrogenase type III (17beta-HSD3). Prostate 2005;65:159-170.
26. Maltais R, Luu-The V, Poirier D: Synthesis and optimization of a new family of type 3 17beta-hydroxysteroid dehydrogenase inhibitors by parallel liquid-phase chemistry. J Med Chem 2002;45:640-653.